Commonwealth Equity Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.68M Sell
154,252
-58,055
-27% -$4.64M 0.01% 899
2025
Q4
$20.2M Sell
212,307
-17,247
-8% -$1.69M 0.03% 556
2025
Q3
$22.4M Sell
229,554
-7,793
-3% -$807K 0.03% 521
2025
Q2
$25.5M Sell
237,347
-16,017
-6% -$1.62M 0.03% 495
2025
Q1
$25.6M Buy
253,364
+25,449
+11% +$2.56M 0.04% 467
2024
Q4
$20.4M Buy
227,915
+16,054
+8% +$1.41M 0.03% 524
2024
Q3
$17.8M Buy
211,861
+392
+0.2% +$30.9K 0.03% 566
2024
Q2
$16.3M Buy
211,469
+8,780
+4% +$643K 0.03% 590
2024
Q1
$13.9M Sell
202,689
-4,612
-2% -$297K 0.02% 643
2023
Q4
$12M Buy
207,301
+5,937
+3% +$317K 0.02% 653
2023
Q3
$10.6M Buy
201,364
+13,121
+7% +$688K 0.02% 648
2023
Q2
$10.2M Buy
188,243
+46,423
+33% +$2.42M 0.02% 674
2023
Q1
$7.09K Sell
141,820
-2,761
-2% -$130K 0.01% 836
2022
Q4
$6.69M Buy
144,581
+29,146
+25% +$1.26M 0.02% 821
2022
Q3
$4.47M Sell
115,435
-5,381
-4% -$216K 0.01% 942
2022
Q2
$4.5M Sell
120,816
-4,624
-4% -$188K 0.01% 950
2022
Q1
$5.55M Sell
125,440
-9,936
-7% -$431K 0.01% 901
2021
Q4
$5.75M Buy
135,376
+1,982
+1% +$83.3K 0.01% 862
2021
Q3
$5.79M Buy
133,394
+3,704
+3% +$164K 0.01% 795
2021
Q2
$5.54M Buy
129,690
+3,218
+3% +$135K 0.01% 806
2021
Q1
$4.89M Sell
126,472
-2,746
-2% -$104K 0.01% 794
2020
Q4
$4.64M Buy
129,218
+1,069
+0.8% +$38.5K 0.01% 754
2020
Q3
$4.9M Buy
128,149
+641
+0.5% +$24.7K 0.02% 651
2020
Q2
$4.48M Sell
127,508
-14,821
-10% -$534K 0.02% 644
2020
Q1
$4.64M Sell
142,329
-3,349
-2% -$131K 0.02% 578
2019
Q4
$6.59M Buy
145,678
+30,761
+27% +$1.29M 0.03% 539
2019
Q3
$4.67M Buy
114,917
+32,380
+39% +$1.37M 0.02% 621
2019
Q2
$3.55M Buy
82,537
+4,078
+5% +$157K 0.02% 691
2019
Q1
$3.01M Buy
78,459
+3,171
+4% +$121K 0.01% 738
2018
Q4
$2.66M Buy
75,288
+6,083
+9% +$221K 0.01% 709
2018
Q3
$2.66M Buy
69,205
+5,425
+9% +$189K 0.01% 794
2018
Q2
$2.09M Sell
63,780
-7,499
-11% -$226K 0.01% 881
2018
Q1
$1.95M Buy
71,279
+1,850
+3% +$50.3K 0.01% 880
2017
Q4
$1.72M Sell
69,429
-2,540
-4% -$70.1K 0.01% 932
2017
Q3
$2.1M Buy
71,969
+12,557
+21% +$347K 0.01% 781
2017
Q2
$1.65M Buy
59,412
+3,040
+5% +$80.7K 0.01% 888
2017
Q1
$1.4M Buy
56,372
+4,915
+10% +$120K 0.01% 943
2016
Q4
$1.11M Sell
51,457
-17
-0% -$371 0.01% 977
2016
Q3
$1.23M Sell
51,474
-209
-0.4% -$4.99K 0.01% 902
2016
Q2
$1.21M Buy
51,683
+316
+0.6% +$6.84K 0.01% 887
2016
Q1
$966K Buy
51,367
+246
+0.5% +$4.32K 0.01% 959
2015
Q4
$943K Buy
51,121
+6,464
+14% +$116K 0.01% 965
2015
Q3
$733K Sell
44,657
-8,399
-16% -$144K 0.01% 1039
2015
Q2
$939K Buy
53,056
+4,350
+9% +$77.7K 0.01% 994
2015
Q1
$865K Buy
48,706
+1,708
+4% +$27K 0.01% 1028
2014
Q4
$623K Buy
46,998
+7,436
+19% +$95.1K 0.01% 1142
2014
Q3
$467K Sell
39,562
-11,077
-22% -$139K 0.01% 1285
2014
Q2
$647K Buy
50,639
+10,513
+26% +$137K 0.01% 1090
2014
Q1
$543K Sell
40,126
-57,372
-59% -$753K 0.01% 1121
2013
Q4
$1.17M Sell
97,498
-15,582
-14% -$184K 0.02% 685
2013
Q3
$1.33M Sell
113,080
-15,077
-12% -$163K 0.02% 599
2013
Q2
$1.19M Buy
+128,157
New +$1.09M 0.02% 603

Other funds holding BSX